Erlotinib Viatris

Erlotinib Viatris is an oral medication used to treat certain types of cancer. This medication works by targeting specific proteins to help slow the growth of cancer cells. Erlotinib is commonly prescribed for non-small cell lung cancer and pancreatic cancer.

Erlotinib Viatris is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It is a targeted therapy that works by inhibiting the epidermal growth factor receptor (EGFR), which can help to slow the growth and spread of cancer cells. Patients often wonder, 'What is Erlotinib used for?' and the answer is that it is specifically designed to target and interfere with the growth of cancer cells in these types of cancer.

Common effects of Erlotinib Viatris may include skin rash, diarrhea, and fatigue. Some patients may also experience appetite loss, nausea, and dry skin. These effects can vary in severity and may not affect everyone who takes the medication. It is important to discuss any persistent or severe side effects with a healthcare provider.

Erlotinib Viatris should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should avoid breaking or crushing the tablets unless instructed to do so. Additionally, pregnant women or those planning to become pregnant should consult their healthcare provider before taking this medication.

Erlotinib Viatris can interact with certain medications, including those that are metabolized by the liver's cytochrome P450 system. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs, herbal supplements, and vitamins. Alcohol consumption should also be discussed with a healthcare provider, as it may affect the efficacy and safety of Erlotinib.